Search Results - "Maluenda, M D"

Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients by Forns, X, Maluenda, M D, López-Labrador, F X, Ampurdanès, S, Olmedo, E, Costa, J, Simmonds, P, Sánchez-Tapias, J M, Jimenez De Anta, M T, Rodés, J

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Preoperative detection of gastrointestinal neuroendocrine tumors using endoscopic ultrasonography by Varas Lorenzo, M J, Miquel Collell, J M, Maluenda Colomer, M D, Boix Valverde, J, Armengol Miró, J R

“…Almost 30% of gastroenteropancreatic neuroendocrine tumors (GEPET) escape preoperative identification using standard imaging techniques. The goal of this…”
Get full text

Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy by Qian, C, Camps, J, Maluenda, M D, Civeira, M P, Prieto, J

“…Hepatitis C virus (HCV) is a positive-stranded RNA virus which replicates through a negative-stranded RNA intermediate. Using a PCR procedure to detect…”
Get more information

Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum by Ampurdanés, Sergi, Olmedo, Eva, Maluenda, Maria D., Forns, Xavier, López-Labrador, Francesc X., Costa, Josep, Sánchez-Tapias, Jose M., Jimenez de Anta, Maria T., Rodés, Juan

“…Background/Aims: Prediction of response to interferon therapy is important in the management of chronic hepatitis C. Pre-therapy data are valuable but they may…”
Get full text

Comparative study of a modified competitive RT-PCR and amplicor HCV monitor assays for quantitation of hepatitis C virus RNA in serum by Olmedo, Eva, Costa, Josep, López-Labrador, Fancesc X., Forns, Xavier, Ampurdanés, Sergi, Maluenda, Maria D., Guilera, Magdalena, Sánchez-Tapias, Jose M., Rodes, Joan, Jimenez de Anta, Maria T.

“…A modified competitive RT‐PCR (mcRT‐PCR) to measure HCV RNA in serum and the Amplicor HCV Monitor assay were compared. For mcRT‐PCR, the RNA extracted was…”
Get full text

Transcatheter Tricuspid Valve Implantation of NaviGate Bioprosthesis in a Preclinical Model by Navia, Jose L., MD, Kapadia, Samir, MD, Elgharably, Haytham, MD, Maluenda, Gabriel, MD, Bartuś, Krzysztof, MD, Baeza, Cristian, MD, Nair, Rajesh K., MD, Rodés-Cabau, Josep, MD, Beghi, Cesare, MD, Quijano, Rodolfo C., MD, PhD

“…Visual Abstract…”
Get full text

Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement by Barbash, Israel M., MD, Ben-Dor, Itsik, MD, Dvir, Danny, MD, Maluenda, Gabriel, MD, Xue, Zhenyi, MS, Torguson, Rebecca, MPH, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background Patients undergoing transcatheter aortic valve replacement (TAVR) are at increased risk for acute kidney injury (AKI). The Valve Academic Research…”
Get full text

Complications and Outcome of Balloon Aortic Valvuloplasty in High-Risk or Inoperable Patients by Ben-Dor, Itsik, MD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Goldstein, Steven A., MD, Syed, Asmir I., MD, Gaglia, Michael A., MD, MSc, Weissman, Gaby, MD, Maluenda, Gabriel, MD, Gonzalez, Manuel A., MD, MPH, Wakabayashi, Kohei, MD, Collins, Sara D., MD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Xue, Zhenyi, MS, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Objectives This study aimed to determine the success, complications, and survival of patients after balloon aortic valvuloplasty (BAV). Background The…”
Get full text

Preoperative detection of gastrointestinal neuroendocrine tumors using endoscopic ultrasonography Detección preoperatoria de los tumores neuroendocrinos digestivos mediante ultrasonografía endoscópica by M. J. Varas Lorenzo, J. M. Miquel Collell, M. D. Maluenda Colomer, J. Boix Valverde, J. R. Armengol Miró

“…Objective: almost 30% of gastroenteropancreatic neuroendocrine tumors (GEPET) escape preoperative identification using standard imaging techniques. The goal of…”
Get full text

Clinical Profile, Prognostic Implication, and Response to Treatment of Pulmonary Hypertension in Patients With Severe Aortic Stenosis by Ben-Dor, Itsik, MD, Goldstein, Steven A., MD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Maluenda, Gabriel, MD, Li, Yanlin, MD, Syed, Asmir I., MD, Gonzalez, Manuel A., MD, MPH, Gaglia, Michael A., MD, MSc, Wakabayashi, Kohei, MD, Delhaye, Cedric, MD, Belle, Loic, MD, Wang, Zuyue, MD, Collins, Sara D., MD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Aderotoye, Adefolaseyi, MS, Xue, Zhenyi, MS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Epstein, Stephen E., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…The incidence, correlates, and prognostic implications of pulmonary hypertension (PH) are unclear in patients with severe aortic stenosis (AS). We studied 509…”
Get full text

Relation of Proton Pump Inhibitor Use After Percutaneous Coronary Intervention With Drug-Eluting Stents to Outcomes by Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Hanna, Nicholas, MD, Gonzalez, Manuel A., MD, MPH, Collins, Sara D., MD, Syed, Asmir I., MD, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Delhaye, Cedric, MD, Wakabayashi, Kohei, MD, Xue, Zhenyi, MS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Recent evidence has shown that clopidogrel and proton pump inhibitors (PPIs) are metabolized by the same pathway and that patients taking both drugs have…”
Get full text

Frequency of Conduction Disturbances After Edwards SAPIEN Percutaneous Valve Implantation by Laynez, Ana, MD, Ben-Dor, Itsik, MD, Barbash, Israel M., MD, Hauville, Camille, MD, PhD, Sardi, Gabriel, MD, Maluenda, Gabriel, MD, Xue, Zhenyi, MS, Satler, Lowell F., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Disturbances in atrioventricular conduction and the additional need for a permanent pacemaker are recognized complications after transcatheter aortic valve…”
Get full text

Comparison of Outcome of Higher Versus Lower Transvalvular Gradients in Patients With Severe Aortic Stenosis and Low (<40%) Left Ventricular Ejection Fraction by Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Iyasu, Getachew D., MD, Laynez-Carnicero, Ana, MD, Hauville, Camille, MD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Xue, Zhenyi, MS, Goldstein, Steven A., MD, PhD, Lindsay, Joseph, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Left ventricular systolic dysfunction in patients with severe aortic stenosis (AS) is associated with poor outcome. This analysis was designed primarily to…”
Get full text

Safety and Efficacy of the XIENCE V Everolimus-Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice by Waksman, Ron, MD, Barbash, Israel M., MD, Dvir, Danny, MD, Torguson, Rebecca, MPH, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Xue, Zhenyi, MD, Satler, Lowell F., MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD

“…Data from randomized clinical trials have shown the safety and efficacy of the XIENCE V in selected populations. However, limited data are available comparing…”
Get full text

Prognostic Value of Hemoglobin A1C Levels in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention With Stent Implantation by Lemesle, Gilles, MD, Bonello, Laurent, MD, de Labriolle, Axel, MD, Maluenda, Gabriel, MD, Syed, Asmir I., MD, Collins, Sara D., MD, Ben-Dor, Itsik, MD, Torguson, Rebecca, MPH, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…The optimal glycosylated hemoglobin (HbA1C) target in diabetic patients is a subject of ongoing controversy that may be especially pertinent in diabetic…”
Get full text

Association Between Bleeding Severity and Long-Term Mortality in Patients Experiencing Vascular Complications After Percutaneous Coronary Intervention by Romaguera, Rafael, MD, Wakabayashi, Kohei, MD, Laynez-Carnicero, Ana, MD, Sardi, Gabriel, MD, Maluenda, Gabriel, MD, Ben-Dor, Itsik, MD, Torguson, Rebecca, MPH, Kent, Kenneth M., MD, Satler, Lowell F., MD, Suddath, William O., MD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Vascular complications (VCs) occur in 3% to 8% of percutaneous coronary interventions (PCIs). However, only a portion of patients who experience VCs bleed…”
Get full text

Impact of Chronic Obstructive Pulmonary Disease on Acute-Phase Outcome of Myocardial Infarction by Wakabayashi, Kohei, MD, Gonzalez, Manuel A., MD, MPH, Delhaye, Cedric, MD, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Collins, Sara D., MD, Syed, Asmir I., MD, Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Xue, Zhenyi, MS, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Several reports have alluded to the adverse effect of chronic obstructive pulmonary disease (COPD) on long-term prognosis of patients with myocardial…”
Get full text

Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents by Ben-Dor, Itsik, MD, Torguson, Rebecca, MPH, Scheinowitz, Mickey, PhD, Li, Yanlin, MD, Delhaye, Cedric, MD, Wakabayashi, Kohei, MD, Maluenda, Gabriel, MD, Syed, Asmir I., MD, Collins, Sara D., MD, Gonzalez, Manuel A., MD, MPH, Gaglia, Michael A., MD, MSc, Xue, Zhenyi, MS, Kaneshige, Kimberly, BS, Satler, Lowell F., MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background Nuisance bleeding (NB) after dual antiplatelet therapy (DAPT) is not well characterized despite its potential to impact patient compliance. We…”
Get full text

Acute Myocardial Infarction After Left-Heart Catheterization in a Patient With Severe Calcified Bicuspid Aortic Stenosis by Dauvergne, Christian, MD, Araya, Mario, MD, Valenzuela, Julia, MD, Meneses, Manuel, MD, Selman, Rafael, MD, Maluenda, Gabriel, MD

Get full text

Outcome of Percutaneous Coronary Intervention Utilizing Drug-Eluting Stents in Patients With Reduced Left Ventricular Ejection Fraction by Sardi, Gabriel L., MD, Gaglia, Michael A., MD, MSc, Maluenda, Gabriel, MD, Torguson, Rebecca, MPH, Laynez-Carnicero, Ana, MD, Ben-Dor, Itsik, MD, Hauville, Camille, MD, Xue, Zhenyi, MS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Ischemic cardiomyopathy with depressed left ventricular ejection fraction (LVEF) is predictive of death after percutaneous coronary intervention (PCI), but its…”
Get full text